Saide capsules will be raised from 70 yuan to 500 yuan, causing grief and curses from patients. The Taiwan Liver Cancer Medical Association pointed out yesterday that no country in the world has approved Saide for the treatment of liver cancer. When there is no medicine available, patients are advised to try it temporarily. Now that the price has risen sharply, it is necessary to carefully evaluate whether it is suitable for the treatment of liver cancer. (Readers, have you seen it? Am I wrong? Patients with terminal liver cancer should seek Chinese medicine for treatment. Using Chinese medicine to prolong life is definitely better than Western medicine.)
Dr. Chen Guanyang, supervisor of the Taiwan Liver Cancer Medical Association, said that although Saide can inhibit tumor angiogenesis, its curative effect on liver cancer is not yet clear. It is only used experimentally at present and needs to be reported to the Department of Health.
Department of Health: Physicians are responsible for off-label use. (Western medicine can still be sold if it is not approved. If it is traditional Chinese medicine, the attitude of the Department of Health is definitely not the same.)
Liu Liling, deputy director of the Drug Administration Department of the Department of Health, said that the consequences of such "off-label" use must be borne by the physician himself.
Chen Guanyang pointed out that Saide is an old drug with a new application. Although it can inhibit tumor angiogenesis, there is no global rigorous experimental support for its effect on liver cancer. There are only regional reports. At present, China has the most experience in using it. It is rarely used, and the Department of Health currently only approves Saide for the treatment of "multiple myeloma" and "leprosy erythema nodosum". (This kind of medicine can’t treat these two diseases. It’s just that there is no medicine in Western medicine at present, so I have to use this rotten medicine. Using this kind of medicine, the side effects are definitely more serious than the original disease.)
Chen Guanyang said that in the past, because of the low price of Saide, patients would be advised to give it a try. Now, a drug has increased from 70 yuan to 500 yuan. Many patients who have to take four pills a day spend as much as 60,000 yuan a month. In the future, he will advise patients to take it for three months first. If the cancer indicators do not drop, they should not continue to take it. (This western doctor would rather see the patient face death than recommend the patient to go to Chinese medicine for treatment. Is he really a good doctor?)
Pharmaceutical factory: has submitted an application to the Department of Health
Zhang Zhimeng, spokesperson of Dongyang Pharmaceutical, said that there are many documents confirming that Saide has curative effect on liver cancer. Dongyang has applied to the Department of Health for a new indication for the treatment of liver cancer. However, the Department of Health believes that the information is not enough and requires Dongyang to supplement it. The application process continues. middle. (This is the Western Pharmaceutical Factory talking to itself. There is no evidence and no real literature records at all. Only the Western Pharmaceutical Factory writes a one-sided statement that is beneficial to itself.)
Only Lesava has been approved by European and American governments
Chen Guanyang pointed out that the only target drug proven to treat liver cancer is "Nexavar" (Nexavar), which has been approved by the US and European governments. The life expectancy is 2.3 months, but the Department of Health has not yet approved it. Patients must apply for a project, and the monthly drug fee is as high as 160,000 yuan. (Here it is explained that it can only be extended by 2.3 months. This is still a doubt, but at present I use Chinese medicine to treat liver cancer, and the record of life extension is at least half a year, and the cost of Chinese medicine is very cheap, 16 months a month. Wanben is the price obtained by western physicians colluding with western medicine factories and sharing the benefits privately.)
Zhang Zhimeng emphasized that the original price of Saide was 59.44 yuan a piece, which was set 12 years ago. This time, it was raised to 408 yuan to reflect the research and development costs. Most hospitals will charge management fees at their discretion. That's why one will sell for five hundred yuan. Patients from low-income households can use it free of charge if they present a certificate to the hospital. (Side, a demon drug, has been banned all over the world for many years, and now I don’t know who approved it to continue to be used.)
What a vicious western medicine factory and the Department of Health
Readers, please remember that if you encounter a patient with terminal liver cancer, please suggest him to seek medical treatment from the nearest Chinese medicine doctor. Even if he is not cured, it can definitely prolong the life of the patient. Well, using traditional Chinese medicine to prolong a patient’s life, its effect is absolutely superior to that of western medicine. Readers must have confidence in Chinese medicine, not to mention the worst Said pill, even the "Lesava" mentioned in the previous article is very reluctant. The real effect of the medicine is still uncertain. The western medicine factory said that it can live longer by 2.3 months. What data are they based on? They are all false data.
Western medicine is often very accurate in predicting the death of patients, because most patients die because of the overtreatment of Western medicine, not because of illness, so when Western medicine tells patients that they can only live for three months, they are very accurate. At this time, after patients come to Chinese medicine for treatment, they can definitely live for more than three months. I have many patients who were originally determined by Western medicine to die. After my treatment, they all survived. During the annual physical examination, these Western doctors often ask my patients, strange, why are you still alive?
